A new study confirms that cannabis use is related to impaired and lasting effects on adolescent cognitive development.
Researchers report ketamine’s antidepressive effects require activation of opioid receptors in the brain. The study highlights the interaction between depression, pain and opioid addiction.
A nasal spray formulation of ketamine shows promise in the rapid treatment of symptoms of major depression and suicidal thoughts, according to a new study published online today in The American Journal of Psychiatry (AJP).
Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain in patients who have not been helped by other treatments, suggests a study being presented at the ANESTHESIOLOGY® 2017 annual meeting. The study of 61 patients found that almost 75 percent experienced an improvement in their migraine intensity after a three- to seven-day course of inpatient treatment with ketamine.
UNSW researchers at Black Dog Institute have preliminary evidence that suggests ketamine is effective as an antidepressant when delivered to elderly patients in repeated intravenous doses.